Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,530
datasets available to search
ShareScore release 0.9.0
Dataset results
3,530 results for “Non-small cell lung cancer;”
Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT01661790. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT03048500. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00558636. IPD Sharing: Not stated. Countries: 6. Publications: 0.
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
ClinicalTrials.gov study NCT07323732. IPD Sharing: YES. Countries: 1. Publications: 0.
Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00401778. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Erlotinib [Tarceva] as Monotherapy or Intermittent Dosing With Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer. (TALISMAN)
ClinicalTrials.gov study NCT01204697. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT07154290. IPD Sharing: YES. Countries: 0. Publications: 0.
Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT03095612. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT02117024. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT04513925. IPD Sharing: YES. Countries: 26. Publications: 0.
Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00385996. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03455556. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00352690. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.
ClinicalTrials.gov study NCT04642469. IPD Sharing: YES. Countries: 25. Publications: 0.
Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment
ClinicalTrials.gov study NCT00606502. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01824901. IPD Sharing: NO. Countries: 1. Publications: 0.
Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03737994. IPD Sharing: YES. Countries: 1. Publications: 0.
Indirect comparison between immunotherapy alone and immunotherapy plus chemotherapy as first-line treatment for advanced non-small cell lung cancer: A systematic review
Open the record for dataset details and reuse information.
Data from: Downregulation of circATXN7 represses non-small cell lung cancer growth by releasing miR-7-5p
Open the record for dataset details and reuse information.
Data from: 18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) – A prospective externally validated study
Open the record for dataset details and reuse information.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.